We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Capillary and Venous Lactate Compared in ED Patients

By LabMedica International staff writers
Posted on 16 Apr 2019
Print article
Image: The Automatic QC RAPID Systems RAPIDPoint 500 blood gas analyzer (Photo courtesy of Siemens Healthcare).
Image: The Automatic QC RAPID Systems RAPIDPoint 500 blood gas analyzer (Photo courtesy of Siemens Healthcare).
Elevated lactate levels are a common finding in acutely unwell patients. Blood lactate level is a good predictor of patient outcome and high lactate levels are associated with high morbidity and mortality. Lactate may be detected and measured in all blood samples: arterial, venous and capillary.

Currently, blood lactate can be measured formally in the laboratory, using blood gas analyzers or with handheld devices. Strong correlations have been shown between blood lactate levels in samples analyzed in the central laboratory, by blood gas analyzers and handheld devices. Capillary blood lactate testing with handheld analyzers has great advantages to reduce the time needed for clinical decisions, and for extended use in the prehospital setting.

Emergency department (ED) personnel at the Chinese University of Hong Kong (Shatin, Hong Kong) and their colleagues carried out a prospective observational study of patients presenting to the ED of Prince of Wales Hospital (Shatin, Hong Kong) and 240 patients (mean age 69.9 years) were recruited. Venous and capillary blood samples were collected for lactate analysis. Venous blood samples (approximate 1 mL) were collected by venipuncture while capillary blood samples were collected by finger-prick with a disposable lancet.

Venous lactate levels were measured by blood gas analyzer the Siemens Automatic QC RAPID Systems RAPIDPoint 500 (VL-Ref) served as the reference standard. Capillary lactate levels were immediately analyzed by two handheld lactate analyzers: Nova StatStrip Xpress Lactate Meter (CL-Nova) and Lactate Scout+ (CL-Scout). Venous lactate levels were also measured on the two handheld lactate analyzers. All lactate measurements were performed within 15 minutes after obtaining the venous sample.

The scientists reported that the results of VL-Ref ranged from 0.70 to 5.38 mmol/L (mean of 1.96 mmol/L). Regarding capillary lactate measurements, the bias (mean difference) between VL-Ref and CL-Scout+ was −0.22 with 95% limits of agreement (LOA) of −2.17 to 1.73 mmol/L and the bias between VL-Ref and CL-Nova was 0.46, with LOA of −1.08 to 2.00 mmol/L. For venous lactate, results showed the bias between VL-Ref and VL-Scout+ were 0.22 with LOA being −0.46 to 0.90 mmol/L, and the bias between VL-Ref and VL-Nova was 0.83 mmol/L with LOA −0.01 to 1.66 mmol/L.

The author concluded that their study shows poor agreement between capillary lactate and reference values. The study does not support the clinical utility of capillary lactate point-of-care testing (POCT). However, venous lactate measured by Scout+ handheld analyzer may have potential for screening patients who may need further testing. The study was published on April 3, 2019, in the journal BMJ OPEN.

Related Links:
Chinese University of Hong Kong
Prince of Wales Hospital

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: Fingertip blood sample collection on the Babson Handwarmer (Photo courtesy of Babson Diagnostics)

Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection

Warming the hand is an effective way to facilitate blood collection from a fingertip, yet off-the-shelf solutions often do not fulfill laboratory requirements. Now, a unique hand-warming technology has... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.